Muhsen Al-Dhalimy

8.2k citations

28 papers · 6.2k indexed · 4 hit papers · h-index 23

Surgery top 0.5%
Molecular Biology top 2%
Hepatology top 0.2%
Genetics top 0.5%
Genetics top 2%

Co-authors: Markus Grompe Milton J. Finegold Eric LagasseXin WangKen Overturf Linda J. Osborne Irving L. Weissman Michael J. Reitsma
Topics: Metabolism and Genetic Disorders (12 papers)Liver physiology and pathology (9 papers)Pancreatic function and diabetes (6 papers)
Cited by: Hepatology Genetics Surgery
Journals: Nature New England Journal of Medicine Proceedings of the National Academy of Sciences
Partner nations: United States Canada Netherlands

In The Last Decade

Muhsen Al-Dhalimy

28 papers receiving 6.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Purified hematopoietic stem cells can differentiate into hepatocytes in vivo

2000 1.8k citations Eric Lagasse, Heather Connors et al. Nature Medicine profile →
Cell fusion is the principal source of bone-marrow-derived hepatocytes

2003 1.2k citations Xin Wang, Holger Willenbring et al. Nature profile →
Robust expansion of human hepatocytes in Fah−/−/Rag2−/−/Il2rg−/− mice

2007 598 citations Hisaya Azuma, Nicole K. Paulk et al. Nature Biotechnology profile →
Serial transplantation reveals the stem-cell-like regenerative potential of adult mouse hepatocytes.

1997 446 citations Ken Overturf, Muhsen Al-Dhalimy et al. profile →

Peers

Countries citing papers authored by Muhsen Al-Dhalimy

Since Specialization

Citations

This map shows the geographic impact of Muhsen Al-Dhalimy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muhsen Al-Dhalimy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muhsen Al-Dhalimy more than expected).

Fields of papers citing papers by Muhsen Al-Dhalimy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muhsen Al-Dhalimy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muhsen Al-Dhalimy. The network helps show where Muhsen Al-Dhalimy may publish in the future.

Co-authorship network of co-authors of Muhsen Al-Dhalimy

This figure shows the co-authorship network connecting the top 25 collaborators of Muhsen Al-Dhalimy. A scholar is included among the top collaborators of Muhsen Al-Dhalimy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muhsen Al-Dhalimy. Muhsen Al-Dhalimy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Validation of Fanconi anemia complementation Group A assignment using molecular analysis 2009 ·Genetics in Medicine ·Nabil Moghrabi,Monique Johnson,(unknown),(unknown),Muhsen Al-Dhalimy,Susan B. Olson,Markus Grompe,C. Sue Richards	14
2	Tip60 Is Required for DNA Interstrand Cross-link Repair in the Fanconi Anemia Pathway 2008 ·Journal of Biological Chemistry ·James Hejna,Megan Holtorf,(unknown),(unknown),(unknown),Muhsen Al-Dhalimy,Susan B. Olson,Robb E. Moses	24
3	Robust expansion of human hepatocytes in Fah−/−/Rag2−/−/Il2rg−/− micebreakdown → 2007 ·Nature Biotechnology ·Hisaya Azuma,Nicole K. Paulk,Aarati R. Ranade,Craig Dorrell,Muhsen Al-Dhalimy,Ewa Ellis,Stephen C. Strom,Mark A. Kay,Milton J. Finegold,Markus Grompe	598
4	Low Therapeutic Threshold for Hepatocyte Replacement in Murine Phenylketonuria 2005 ·Molecular Therapy ·Kelly Hamman,Heather D. Clark,Eugenio Montini,Muhsen Al-Dhalimy,Markus Grompe,Milton J. Finegold,Cary O. Harding	48
5	Chronic liver disease in murine hereditary tyrosinemia type 1 induces resistance to cell death 2004 ·Hepatology ·Arndt Vogel,Inge E.T. van den Berg,Muhsen Al-Dhalimy,John D. Groopman,Ching-Nan Ou,Olga P. Ryabinina,Mihail S. Iordanov,Milton J. Finegold,Markus Grompe	43
6	Cell fusion is the principal source of bone-marrow-derived hepatocytesbreakdown → 2003 ·Nature ·Xin Wang,Holger Willenbring,Yassmine Akkari,Yumi Torimaru,Mark P. Foster,Muhsen Al-Dhalimy,Eric Lagasse,Milton J. Finegold,Susan B. Olson,Markus Grompe	1202
7	Long-Term Therapy with NTBC and Tyrosine-Restricted Diet in a Murine Model of Hereditary Tyrosinemia Type I 2002 ·Molecular Genetics and Metabolism ·Muhsen Al-Dhalimy,Ken Overturf,Milton J. Finegold,Markus Grompe	65
8	In Vivo Correction of Murine Tyrosinemia Type I by DNA-Mediated Transposition 2002 ·Molecular Therapy ·Eugenio Montini,Patrice K. Held,Meenakshi Noll,(unknown),Muhsen Al-Dhalimy,Milton J. Finegold,Stephen R. Yant,Mark A. Kay,Markus Grompe	112
9	Kinetics of Liver Repopulation after Bone Marrow Transplantation 2002 ·American Journal Of Pathology ·Xin Wang,Eugenio Montini,Muhsen Al-Dhalimy,Eric Lagasse,Milton J. Finegold,Markus Grompe	192
10	Purified hematopoietic stem cells can differentiate into hepatocytes in vivobreakdown → 2000 ·Nature Medicine ·Eric Lagasse,Heather Connors,Muhsen Al-Dhalimy,Michael J. Reitsma,Monika Dohse,Linda J. Osborne,Xin Wang,Milton J. Finegold,Irving L. Weissman,Markus Grompe	1796
11	The Repopulation Potential of Hepatocyte Populations Differing in Size and Prior Mitotic Expansion 1999 ·American Journal Of Pathology ·Ken Overturf,Muhsen Al-Dhalimy,Milton J. Finegold,Markus Grompe	143
12	Ex Vivo Hepatic Gene Therapy of a Mouse Model of Hereditary Tyrosinemia Type I 1998 ·Human Gene Therapy ·Ken Overturf,Muhsen Al-Dhalimy,(unknown),Ching‐Nan Ou,Milton J. Finegold,Markus Grompe	49
13	Serial transplantation reveals stem cell like regenerative potential in parenchymal mouse hepatocytes 1997 ·The FASEB Journal ·Ken Overturf,Muhsen Al-Dhalimy,Milton J. Finegold,Markus Grompe	3
14	Adenovirus-Mediated Gene Therapy in a Mouse Model of Hereditary Tyrosinemia Type I 1997 ·Human Gene Therapy ·Ken Overturf,Muhsen Al-Dhalimy,Ching N. Ou,Milton J. Finegold,Robert M. Tanguay,André Lieber,Mark A. Kay,Markus Grompe	58
15	Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I 1996 ·Nature Genetics ·Ken Overturf,Muhsen Al-Dhalimy,Robert M. Tanguay,Mark Brantly,Ching-Nan Ou,Milton J. Finegold,Markus Grompe	435
16	Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I 1995 ·Nature Genetics ·Markus Grompe,Sven Lindstedt,Muhsen Al-Dhalimy,Nancy G. Kennaway,John Papaconstantinou,Carlos A. Torres‐Ramos,(unknown),Milton J. Finegold	238
17	A Single Mutation of the Fumarylacetoacetate Hydrolase Gene in French Canadians with Hereditary Tyrosinemia Type I 1994 ·New England Journal of Medicine ·Markus Grompe,(unknown),(unknown),Muhsen Al-Dhalimy,(unknown),Robert M. Tanguay	88
18	Mutations of the fumarylacetoacetate hydrolase gene in four patients with tyrosinemia, type I 1993 ·Human Mutation ·Markus Grompe,Muhsen Al-Dhalimy	40
19	Nucleotide sequence of a cDNA encoding murine fumarylacetoacetate hydrolase 1992 ·Biochemical Medicine and Metabolic Biology ·Markus Grompe,Muhsen Al-Dhalimy	13
20	A Taql RFLP at the DRD1 locus 1991 ·Nucleic Acids Research ·M. Litt,Muhsen Al-Dhalimy,Qun Zhou,David K. Grandy,Olivier Civelli	10

About Muhsen Al-Dhalimy

Muhsen Al-Dhalimy is a scholar working on Clinical Biochemistry, Hepatology and Biochemistry, having authored 28 papers that have together received 6.2k indexed citations. Recurring topics across this work include Metabolism and Genetic Disorders (12 papers), Liver physiology and pathology (9 papers) and Pancreatic function and diabetes (6 papers). The work is most often cited by research in Hepatology (2.6k citations), Genetics (1.7k citations) and Surgery (3.0k citations). Muhsen Al-Dhalimy has collaborated with scholars based in United States, Canada and Netherlands. Frequent co-authors include Markus Grompe, Milton J. Finegold, Eric Lagasse, Xin Wang, Ken Overturf, Linda J. Osborne, Irving L. Weissman, Michael J. Reitsma, Heather Connors and Monika Dohse. Their work appears in journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact